Year |
Citation |
Score |
2009 |
Knol AC, Ehst BD, Dompmartin A, Quéreux G, Nguyen JM, Comoz F, Renaut JJ, Khammari A, Vonderheid EC, Dréno B. Toll-like receptor 2, 4, 7 and 9 expression in primary cutaneous CD30+ T-cell lymphoma. The British Journal of Dermatology. 161: 1414-6. PMID 19785598 DOI: 10.1111/j.1365-2133.2009.09470.x |
0.569 |
|
2008 |
Ehst BD, Dréno B, Vonderheid EC. Primary cutaneous CD30+ anaplastic large cell lymphoma responds to imiquimod cream. European Journal of Dermatology : Ejd. 18: 467-8. PMID 18573730 DOI: 10.1684/ejd.2008.0450 |
0.515 |
|
2005 |
Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, Griffith TS, Green DR, Schoenberger SP. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature. 434: 88-93. PMID 15744305 DOI: 10.1038/Nature03337 |
0.685 |
|
2004 |
Richards DM, Dalheimer SL, Ehst BD, Vanasek TL, Jenkins MK, Hertz MI, Mueller DL. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease. Journal of Immunology (Baltimore, Md. : 1950). 172: 3469-79. PMID 15004147 DOI: 10.4049/Jimmunol.172.6.3469 |
0.632 |
|
2003 |
Ehst BD, Ingulli E, Jenkins MK. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 3: 1355-62. PMID 14525595 DOI: 10.1046/J.1600-6135.2003.00246.X |
0.629 |
|
2003 |
Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity. 19: 47-57. PMID 12871638 DOI: 10.1016/S1074-7613(03)00175-4 |
0.51 |
|
2002 |
McSorley SJ, Ehst BD, Yu Y, Gewirtz AT. Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo. Journal of Immunology (Baltimore, Md. : 1950). 169: 3914-9. PMID 12244190 DOI: 10.4049/Jimmunol.169.7.3914 |
0.678 |
|
1996 |
Sperling AI, Auger JA, Ehst BD, Rulifson IC, Thompson CB, Bluestone JA. CD28/B7 Interactions Deliver a Unique Signal to Naive T Cells That Regulates Cell Survival but Not Early Proliferation Journal of Immunology. 157: 3909-3917. PMID 8892622 |
0.612 |
|
Show low-probability matches. |